PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1673826
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1673826
Global Interventional Radiology Market is estimated to be valued at USD 28.83 Bn in 2025 and is expected to reach USD 46.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 28.83 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.90% | 2032 Value Projection: | USD 46.03 Bn |
Interventional radiology relies on minimally invasive image-guided procedures to diagnose and treat diseases. It combines imaging with therapy and is gaining prominence due to advantages such as reduced trauma, shorter hospital stays, lower costs and fewer complications compared to open surgeries. Growing prevalence of chronic diseases like cancer and cardiovascular diseases is a key factor augmenting adoption of interventional radiology procedures worldwide. Furthermore, rising demand for minimally invasive techniques from the rapidly expanding geriatric population is also supporting interventional radiology market growth. However, risks of exposure to radiation, shortage of skilled professionals and high costs associated with IR equipment and procedures may hinder the market to a certain extent during the forecast period.
The global interventional radiology market is driven by factors such as rising geriatric population susceptible to chronic diseases, increasing preference for minimally invasive surgeries, and technological advancements promoting the use of advanced IR devices. As per the United Nations, the population aged 60 years and above is expected to double from 12% to 22% between 2015 and 2050. Additionally, according to the World Health Organization, cancer burden has risen to 18.1 million new cases and 9.6 million cancer deaths in 2018. Furthermore, the demand for less invasive procedures for the diagnosis and treatment of various neurological, oncological, and cardiovascular ailments is on the rise. However, a shortage of skilled radiologists, risk of radiation exposure associated with interventional procedures, and high costs of IR equipment and procedures may restrain the market growth. Conversely, the use of artificial intelligence and robotics can provide novel opportunities for precision-guided procedures and expanded applications of IR in the coming years.
Detailed Segmentation-